195 related articles for article (PubMed ID: 34902735)
1. Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
Li X; Guo T; Feng Q; Bai T; Wu L; Liu Y; Zheng X; Jia J; Pei J; Wu S; Song Y; Zhang Y
Eur J Med Chem; 2022 Jan; 228():114035. PubMed ID: 34902735
[TBL] [Abstract][Full Text] [Related]
2. Advances in antithrombotic agents.
Chakrabarti R; Das SK
Cardiovasc Hematol Agents Med Chem; 2007 Jul; 5(3):175-85. PubMed ID: 17630943
[TBL] [Abstract][Full Text] [Related]
3. Individualized antithrombotic therapy.
Lüscher TF; Steffel J
Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
[TBL] [Abstract][Full Text] [Related]
4. [New agents and challenges in the antithrombotic management of arterial diseases].
Udvardy M; Rák K
Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects and molecular mechanisms of natural products in thrombosis.
Yuan MH; Zhong WX; Wang YL; Liu YS; Song JW; Guo YR; Zeng B; Guo YP; Guo L
Phytother Res; 2024 May; 38(5):2128-2153. PubMed ID: 38400575
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PAI-1: a new anti-thrombotic approach.
Wu Q; Zhao Z
Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):27-42. PubMed ID: 12769655
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
[TBL] [Abstract][Full Text] [Related]
8. Current trends in antithrombotic drug and device development.
Fareed J
Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease.
Schussheim AE; Fuster V
Prog Cardiovasc Dis; 1997; 40(3):205-38. PubMed ID: 9406677
[TBL] [Abstract][Full Text] [Related]
10. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
Lisman T; Kamphuisen PW; Northup PG; Porte RJ
J Hepatol; 2013 Aug; 59(2):358-66. PubMed ID: 23548197
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications.
Gorog DA
J Thromb Thrombolysis; 2018 May; 45(4):593-602. PubMed ID: 29550950
[TBL] [Abstract][Full Text] [Related]
12. Molecular aspects of thrombosis and antithrombotic drugs.
Wu KK; Matijevic-Aleksic N
Crit Rev Clin Lab Sci; 2005; 42(3):249-77. PubMed ID: 16047540
[TBL] [Abstract][Full Text] [Related]
13. [A 50-year history of new drugs in Japan-the development and trends of hemostatics and antithrombotic drugs].
Ozawa H; Abiko Y; Akimoto T
Yakushigaku Zasshi; 2003; 38(1):93-105. PubMed ID: 14570069
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic stewardship: a multidisciplinary team approach towards improving antithrombotic therapy outcomes during and after hospitalisation: a study protocol.
Dreijer AR; Kruip MJ; Diepstraten J; Polinder S; Brouwer R; Leebeek FW; Vulto AG; van den Bemt PM
BMJ Open; 2016 Dec; 6(12):e011537. PubMed ID: 27998897
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of antithrombotic drugs.
Tàssies D
Curr Pharm Des; 2006; 12(19):2425-35. PubMed ID: 16842189
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies for multitarget antithrombotic drugs.
Neves AR; Correia-da-Silva M; Sousa E; Pinto M
Future Med Chem; 2016 Dec; 8(18):2305-2355. PubMed ID: 27845573
[TBL] [Abstract][Full Text] [Related]
17. Historical overview of antithrombotic and thrombolytic therapy.
Sharma GV
Am J Med; 1987 Aug; 83(2A):2-5. PubMed ID: 3307400
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effects of a newly purified fibrinolytic protease from Urechis unicinctus.
Bi Q; Han B; Feng Y; Jiang Z; Yang Y; Liu W
Thromb Res; 2013 Aug; 132(2):e135-44. PubMed ID: 23891134
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic drugs: part I.
Gallus AS; Hirsh J
Drugs; 1976; 12(1):41-68. PubMed ID: 789043
[TBL] [Abstract][Full Text] [Related]
20. Spirulan from blue-green algae inhibits fibrin and blood clots: its potent antithrombotic effects.
Choi JH; Kim S; Kim SJ
J Biochem Mol Toxicol; 2015 May; 29(5):240-8. PubMed ID: 25651404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
